We are live on ! Find out more
SC

Searle & Co Portfolio holdings

AUM $445M
1-Year Est. Return 41.72%
This Fund
S&P 500
This Quarter Est. Return
+9.86%
1 Year Est. Return
+41.72%
3 Year Est. Return
+93.84%
5 Year Est. Return
+130.57%
10 Year Est. Return
+365.42%
AUM
$366M
AUM Growth
+$71.8M
Cap. Flow
+$43.1M
Cap. Flow %
11.79%
Top 10 Hldgs %
41.16%
Holding
166
New
22
Increased
47
Reduced
25
Closed
7

Top Buys

Rank Stock Value
1
PG icon
Procter & Gamble
PG
+$8.54M
2
XOM icon
ExxonMobil
XOM
+$8.27M
3
FITB
Fifth Third Bancorp
FITB
+$4.58M
4
BRK.B icon
Berkshire Hathaway Class B
BRK.B
+$4.05M
5
LLY icon
Eli Lilly
LLY
+$3.11M

Top Sells

Rank Stock Value
1
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
+$2.47M
2
CC icon
Chemours
CC
+$1.08M
3
PFE icon
Pfizer
PFE
+$740K
4
BN icon
Brookfield
BN
+$707K
5
GE icon
GE Aerospace
GE
+$450K

Sector Composition

Rank Sector Weight
1 Financials 23.37%
2 Technology 16.92%
3 Healthcare 13.29%
4 Industrials 11.54%
5 Consumer Staples 9.83%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
DOV icon
151
Dover
DOV
$27.6B
$231K 0.06%
+1,500
New +$210K
BAM icon
152
Brookfield Asset Management
BAM
$77.3B
$229K 0.06%
+5,662
New +$191K
IXN icon
153
iShares Global Tech ETF
IXN
$8.32B
$205K 0.06%
+3,000
New +$189K
EEM icon
154
iShares MSCI Emerging Markets ETF
EEM
$28.8B
$201K 0.06%
+5,000
New +$193K
HRTX icon
155
Heron Therapeutics
HRTX
$93.9M
$145K 0.04%
85,250
– –
ABCL icon
156
AbCellera Biologics
ABCL
$1.74B
$79.4K 0.02%
13,900
– –
PLBY icon
157
Playboy Inc
PLBY
$128M
$72.3K 0.02%
72,253
– –
VGZ icon
158
Vista Gold
VGZ
$251M
$12.2K ﹤0.01%
27,000
– –
OCS icon
159
Oculis Holding
OCS
$683M
$11K ﹤0.01%
+10,000
New +$104K
BN icon
160
Brookfield
BN
$104B
– –
-33,750
Closed -$707K
CC icon
161
Chemours
CC
$2.5B
– –
-38,568
Closed -$1.08M
GE icon
162
GE Aerospace
GE
$374B
– –
-5,098
Closed -$450K
SPXS icon
163
Direxion Daily S&P 500 Bear 3x ETF
SPXS
$337M
– –
-1,075
Closed -$170K
VTRS icon
164
Viatris
VTRS
$20.4B
– –
-19,966
Closed -$197K
WBD icon
165
Warner Bros
WBD
$65.9B
– –
-10,350
Closed -$112K
HZNP
166
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
– –
-21,350
Closed -$2.47M
3 4 5 6
7

Similar funds

RWM
Rialto Wealth Management Syracuse, New York $445M AUM 15.58% 1-Year Est. Return
BI
Bulldog Investors Saddle Brook, New Jersey $445M AUM 2.55% 1-Year Est. Return
WC
Weil Company San Diego, California $445M AUM 14.95% 1-Year Est. Return
MLIC
Mandatum Life Insurance Company Helsinki, Finland $445M AUM 26.43% 1-Year Est. Return
AFA
Abacus FCF Advisors Orlando, Florida $444M AUM 44.44% 1-Year Est. Return
SGCM
Sand Grove Capital Management London, United Kingdom $444M AUM 131.11% 1-Year Est. Return
WCP
Welch Capital Partners Harrison, New York $444M AUM 21.45% 1-Year Est. Return
ACA
Aspire Capital Advisors Seattle, Washington $444M AUM 16.47% 1-Year Est. Return

Searle & Co's Q4 2023 Portfolio in Review

As of Q4 2023, Searle & Co held 166 positions worth $366M, up 24% from $294M the previous quarter. Its ten largest holdings account for 41% of the portfolio.

Searle & Co deployed $43.1M of net new capital in Q4 2023, opening 22 new positions and adding to 47 existing holdings. Its largest new stake was Fifth Third Bancorp: 165,037 shares worth $5.69M.

By sector, the portfolio is most concentrated in Financials at 23% of assets, up from 20% a quarter earlier, followed by Technology and Healthcare.

On the sell side, the largest reduction was Pfizer, an estimated $740K trimmed.

  • Searle & Co's largest Q4 2023 buy was Fifth Third Bancorp: 165,037 shares worth $5.69M.
  • Searle & Co added most to Procter & Gamble in Q4 2023, an estimated $8.54M increase.
  • Searle & Co's biggest Q4 2023 reduction was Pfizer, cutting an estimated $740K.
  • Searle & Co fully exited Horizon Therapeutics Public Limited Company Ordinary Shares in Q4 2023, selling an estimated $2.47M.
  • Searle & Co's ten largest holdings make up 41% of its $366M portfolio in Q4 2023.
  • Searle & Co opened 22 new positions and closed 7 in Q4 2023.
  • Searle & Co's portfolio value rose 24% quarter-over-quarter to $366M.

Based on Searle & Co's 13F filing for Q4 2023, filed 6 Feb 2024.